1. 1h-3-benzazepine-7,8-diol, 2,3,4,5-tetrahydro-1-phenyl-
2. 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1h-3-benzazepine
3. R-sk And F 38393
4. Rsk And F 38393
5. Sk And F 38393
6. Sk And F-38393
7. Sk And F38393
8. Skf 38393
9. Skf 38393 A
10. Skf 38393-a
11. Skf 38393a
12. Skf-38393
13. Skf38393
1. 62717-42-4
2. Skf 38393 Hydrochloride
3. Skf38393 Hcl
4. Skf-38393 Hydrochloride
5. Skf 38393 (hydrochloride)
6. (+/-)-skf-38393 Hydrochloride
7. Skf-38393 Hcl
8. Skf-38393a
9. Wiv5r2g7vp
10. 1h-3-benzazepine-7,8-diol, 2,3,4,5-tetrahydro-1-phenyl-, Hydrochloride
11. 2-phenyl-4-azabicyclo[5.4.0]undeca-7,9,11-triene-9,10-diol
12. (r)-skf 38393 (hydrochloride)
13. Nsc-320959
14. 81633-77-4
15. 62717-42-4 (hcl)
16. 2,3,4,5-tetrahydro-1-phenyl-1h-3-benzazepine-7,8-diol Hydrochloride
17. (+/-)-1-phenyl-2,3,4,5-tetrahydro-(1h)-3-benzazepine-7,8-diol Hydrochloride
18. (+/-)-skf-38393 Hydrochloride;skf-38393a
19. Chembl542700
20. Sr-01000075378
21. Skf 38393a
22. Unii-wiv5r2g7vp
23. Skf-38393hydrochloride
24. C16h17no2.hcl
25. Mls000859931
26. Skf 38393 Hcl
27. Schembl3425787
28. (y)-skf-38393 Hydrochloride
29. Dtxsid20936175
30. (?)-skf-38393 Hydrochloride
31. Bcp28880
32. Ex-a3563
33. Tox21_500436
34. 1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine-7,8-diol Hydrochloride
35. Hy-12520a
36. Nsc320959
37. Akos016012197
38. Ccg-221740
39. Cs-5354
40. Lp00436
41. Nsc 320959
42. Ncgc00093856-01
43. Ncgc00261121-01
44. Ac-32754
45. As-16874
46. Smr000326792
47. D-047
48. Eu-0100436
49. S7993
50. (+/-)-skf-38393 Hydrochloride, Crystalline
51. C75947
52. ( Inverted Question Mark)-skf-38393 Hydrochloride
53. Sr-01000075378-1
54. ( Inverted Exclamation Marka)-skf38393 Hydrochloride
55. ( Inverted Exclamation Marka)-skf-38393 Hydrochloride
56. (+/-)-skf-38393 Hydrochloride D1 Dopamin E Receptor
57. (+/-)-skf-38393 Hydrochloride, Crystalline, >=98% (hplc)
58. (+/-)-1-phenyl-2,3,4-tetrahydro(1h)-3-benzapezine-7,8-diol Hcl
59. 5-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine-7,8-diol;hydrochloride
60. (+/-)-1-phenyl-2,3,4,5-tetrahydro-(1h)-3-benzazepine-7,8- Diol Hydrobromide
61. (+/-)-1-phenyl-2,3,4-tetrahydro(1h)-3-benzapezine-7,8-diol Hydrochloride
62. 1h-3-benzazepine-7,8-diol, 2,3,4,5-tetrahydro-1-phenyl-, Hydrochloride (1:1)
63. 1h-3-benzazepine-7,8-diol, 2,3,4,5-tetrahydro-1-phenyl-,?hydrochloride (1:1)
64. ( Inverted Question Mark)-1-phenyl-2,3,4,5-tetrahydro-(1h)-3-benzazepine-7,8-diol Hydrochloride
Molecular Weight | 291.77 g/mol |
---|---|
Molecular Formula | C16H18ClNO2 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 1 |
Exact Mass | 291.1026065 g/mol |
Monoisotopic Mass | 291.1026065 g/mol |
Topological Polar Surface Area | 52.5 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 291 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Dopamine Agonists
Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)